Search

This is the second regulatory approval of the cell-based immunotherapy for a blood cancer.

… Thursday, October 19, 2017 Summary People with an aggressive form of lymphoma that is no longer responding to chemotherapy may now be eligible to receive a novel cell-based immunotherapy called CAR T . Previously, this treatment was available only to people participating in clinical trials . For the

Learn from an MSK specialist in cancer care for the Latino community about screening for colorectal cancer, to help prevent the disease.

… Friday, February 28, 2025 Colorectal cancer is a leading cause of cancer deaths among people within the Latino/Hispanic community. But Rosario Costas-Muñiz, PhD , of Memorial Sloan Kettering Cancer Center (MSK), wants people to know the good news about screening tests for colorectal cancer , which can

Obtenga más información por parte de un miembro de MSK especialista en la atención oncológica de la comunidad latina sobre las pruebas de detección del cáncer colorrectal para ayudar a prevenir la enfermedad.

… Friday, February 28, 2025 El cáncer colorrectal es la causa principal de muerte por cáncer entre los miembros de la comunidad hispanolatina. Sin embargo, Rosario Costas-Muñiz, PhD , del Memorial Sloan Kettering Cancer Center (MSK), quiere que las personas conozcan las buenas noticias sobre las pruebas

Meet Elizabeth Rodriguez, Director of Nursing for the David H. Koch Center for Cancer Care at Memorial Sloan Kettering.

… Friday, April 2, 2021 Summary Elizabeth Rodriguez, DNP, RN , is Director of Nursing for the David H. Koch Center for Cancer Care. Her contributions were central to MSK’s response to the COVID-19 pandemic. Early on, she focused on ramping up remote work capabilities and telemedicine efforts in order to

A gene therapy approach could prove effective at treating an inherited blood disorder called beta (β)-thalassemia.

… Thursday, January 6, 2022 After three decades of research, Memorial Sloan Kettering Cancer Center investigators may have found a new treatment option for patients with an inherited blood disorder called beta (β)-thalassemia. The approach, led by MSK physician-scientist Michel Sadelain, involves using

Science could lead to a new type of opioid drug that blocks pain but has a lower potential for addiction or abuse.

… Thursday, January 4, 2018 Summary A multicenter team of researchers is using structural and chemical biology to determine ways to block pain with opioids that have a lower potential for addiction or abuse. The United States is in the midst of an opioid epidemic. According to the Centers for Disease Control

Follow these guidelines for holding difficult yet important end-of-life conversations.

… Thursday, June 20, 2019 Summary End-of-life conversations are never easy. Your care team at Memorial Sloan Kettering is here to listen to your wishes and validate your feelings. Not many people are comfortable talking about death. But sometimes, the only way to get more comfortable with something is

Each summer, four summer students are named Rubin and Sarah Shaps Scholars. They are selected on the basis of their outstanding undergraduate credentials and their performance in our Summer Undergraduate Research Program.

… Tuesday, August 30, 2011 Each summer, four summer students are named Rubin and Sarah Shaps Scholars. They are selected on the basis of their outstanding undergraduate credentials and their performance in our Summer Undergraduate Research Program. Daniel Holohan, a sophomore majoring in Biochemistry/Molecular

Learn how FDA approval of a new multiple myeloma drug will brighten the outlook for people with resistant forms of the disease.

… Tuesday, October 25, 2022 People with multiple myeloma , a rare blood cancer, got good news today when the FDA approved a new drug for resistant forms of the disease. The drug, teclistamab, has been proven effective in treating people with multiple myeloma for whom previous therapies have not worked.

Learn how MSK doctors are exploring the use of less radiation in neuroblastoma treatment so children can avoid side effects.

… Thursday, December 21, 2023 Summary Treatment for high-risk forms of neuroblastoma is effective but can cause serious complications. MSK researchers are investigating using a lower radiation dose to treat this cancer, which occurs in young children. Early results have shown that a reduced radiation dose